FDA product code LDN: Enzymatic Radiochemical Assay, Amikacin

LDN is the FDA product code for enzymatic radiochemical assay, amikacin. It is a Class II device, regulated under 21 CFR 862.3035 and reviewed by the Clinical Toxicology panel. FDA has cleared 3 510(k) submissions under LDN, from 2 different applicants. The average 510(k) review took 43 days (median 47).

Classification

FieldValue
Device nameEnzymatic Radiochemical Assay, Amikacin
Device classClass II
Regulation21 CFR 862.3035
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every LDN clearance

Top LDN applicants

ApplicantClearancesLatest
Syva Co.21983-12-08
Beckman Instruments, Inc.11984-04-02

Most recent LDN clearances

510(k)ApplicantDeviceDecision dateReview days
K840647Beckman Instruments, Inc.AMIKACIN REAGENT TEST KIT1984-04-0247
K833546Syva Co.MODIFICATION OF EMIT AND AMIKACIN ASSAY1983-12-0855
K820440Syva Co.EMIT-AMD AMIKACIN CONTR. (ENZYME IMMUNO1982-03-1526

Recalls for LDN devices

openFDA lists no recalls for product code LDN.

Frequently asked questions

What is FDA product code LDN?

LDN is the FDA product code for enzymatic radiochemical assay, amikacin. It is a Class II device, regulated under 21 CFR 862.3035 and reviewed by the Clinical Toxicology panel.

What device class is LDN?

Class II, regulation 21 CFR 862.3035. Typical premarket route: 510(k).

How long does a 510(k) take for product code LDN?

Across 3 cleared submissions the average was 43 days from receipt to decision (median 47).

Which companies have the most LDN clearances?

Syva Co. (2); Beckman Instruments, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times